company

PHARMA CLINICAL SYSTEMS AS

1386 ASKER

Return on Equity
6,08 %
Current Ratio
13,71
Debt-to-Equity Ratio
0,22
Key figures (NOK)2022
Revenue76 000
Net Income83 000
Total Assets1 691 000
Total Equity1 365 000
Income (NOK)2022
Revenue76 000
Expenditure50 000
Operating Profit26 000
Financial Income57 000
Financial Costs0
Financial Balance57 000
Earnings Before Tax83 000
Tax0
Net Income83 000
Balance (NOK)2022
Total Fixed Assets1 306 000
Total Current Assets384 000
Total Assets1 691 000
Total Retained Equity103 000
Total Equity1 365 000
Total Long-Term Debt298 000
Total Current Debt28 000
Total Equity and Debt1 691 000
Cash flow (NOK)2022
Sales Income76 000
Other Income0
Revenue76 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure50 000
Operating Profit26 000
Financial Income57 000
Financial Costs0
Financial Balance57 000
Dividends0
Net Income83 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets1 306 000
Total Fixed Assets1 306 000
Stock0
Total Investments0
Cash, Bank3 000
Total Current Assets384 000
Total Assets1 691 000
Total Equity1 365 000
Short-Term Group Debt0
Total Long-Term Debt298 000
Creditors4 000
Unpaid Taxes0
Dividends0
Other Current Debt24 000
Total Current Debt28 000
Total Equity and Debt1 691 000
Financial indicators2022
Return on Equity6,08 %
Debt-to-Equity Ratio0,22
Operating Profit Margin34,21 %
Current Ratio13,71
Quick Ratio13,71
Equity Ratio0,81
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English